The goal is to evaluate the therapeutic efficacy of SGLT2 in the modulation of pulmonary pressures and pulmonary hemodynamics and to assess their impact on overall cardiac function, so as to analyze their potential capacity to improve outcomes in HF patients. Here, SLC5A2 is linked to hydrops fetalis.